Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Kaye

Showing results (201-210 of 740) with videos related to

Pageof 74
Sort By:
American Journal of Infection Control|August 23, 2015
Epidemiology of CTX-M-type extended-spectrum β-lactamase-producing Escherichia coli among older adultsSachi Matsubayashi, Keith S Kaye, Sameen Farooq, et al.
Journal of the American Chemical Society|October 31, 2007
Impact of preparation and handling on the hydrogen storage properties of Zn4O(1,4-benzenedicarboxylate)3 (MOF-5)Steven S Kaye, Anne Dailly, Omar M Yaghi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 7, 2020
Reply to Vena et alJason M Pogue, Keith S Kaye, Robert A Bonomo, et al.
The EMBO Journal|May 1, 1984
A close association between sites of DNase I hypersensitivity and sites of enhanced cleavage by micrococcal nuclease in the 5'-flanking region of the actively transcribed ovalbumin geneJ S Kaye, M Bellard, G Dretzen, et al.
Expert Review of Anti-Infective Therapy|April 10, 2013
Carbapenem-resistant Acinetobacter baumannii: epidemiology, surveillance and managementJason M Pogue, Tal Mann, Katie E Barber, et al.
Infectious Diseases and Therapy|March 31, 2017
Minocycline for the Treatment of Multidrug and Extensively Drug-Resistant A. baumannii: A ReviewJennifer N Lashinsky, Oryan Henig, Jason M Pogue, et al.
Infectious Diseases and Therapy|February 27, 2023
Cefiderocol, a Siderophore Cephalosporin, as a Treatment Option for Infections Caused by Carbapenem-Resistant EnterobacteralesKeith S Kaye, Thierry Naas, Jason M Pogue, et al.
Open Forum Infectious Diseases|June 13, 2024
Review of the In Vitro Microbiological Activity of Mecillinam Against Common Uropathogens in Uncomplicated Urinary Tract Infection: Focus on Resistant PathogensThomas P Lodise, Keith S Kaye, Anne Santerre Henriksen, et al.
Journal of Clinical Microbiology|August 30, 2001
PCR detection and molecular identification of Chlamydiaceae speciesJ C Hartley, S Kaye, S Stevenson, et al.
Journal of the American Geriatrics Society|March 23, 2006
Risk factors for surgical site infections in older peopleKeith S Kaye, Richard Sloane, Daniel J Sexton, et al.
Pageof 74

Showing results (201-210 of 740) with videos related to

Sort By:
Pageof 74
American Journal of Infection Control|August 23, 2015
Epidemiology of CTX-M-type extended-spectrum β-lactamase-producing Escherichia coli among older adultsSachi Matsubayashi, Keith S Kaye, Sameen Farooq, et al.
Journal of the American Chemical Society|October 31, 2007
Impact of preparation and handling on the hydrogen storage properties of Zn4O(1,4-benzenedicarboxylate)3 (MOF-5)Steven S Kaye, Anne Dailly, Omar M Yaghi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 7, 2020
Reply to Vena et alJason M Pogue, Keith S Kaye, Robert A Bonomo, et al.
The EMBO Journal|May 1, 1984
A close association between sites of DNase I hypersensitivity and sites of enhanced cleavage by micrococcal nuclease in the 5'-flanking region of the actively transcribed ovalbumin geneJ S Kaye, M Bellard, G Dretzen, et al.
Expert Review of Anti-Infective Therapy|April 10, 2013
Carbapenem-resistant Acinetobacter baumannii: epidemiology, surveillance and managementJason M Pogue, Tal Mann, Katie E Barber, et al.
Infectious Diseases and Therapy|March 31, 2017
Minocycline for the Treatment of Multidrug and Extensively Drug-Resistant A. baumannii: A ReviewJennifer N Lashinsky, Oryan Henig, Jason M Pogue, et al.
Infectious Diseases and Therapy|February 27, 2023
Cefiderocol, a Siderophore Cephalosporin, as a Treatment Option for Infections Caused by Carbapenem-Resistant EnterobacteralesKeith S Kaye, Thierry Naas, Jason M Pogue, et al.
Open Forum Infectious Diseases|June 13, 2024
Review of the In Vitro Microbiological Activity of Mecillinam Against Common Uropathogens in Uncomplicated Urinary Tract Infection: Focus on Resistant PathogensThomas P Lodise, Keith S Kaye, Anne Santerre Henriksen, et al.
Journal of Clinical Microbiology|August 30, 2001
PCR detection and molecular identification of Chlamydiaceae speciesJ C Hartley, S Kaye, S Stevenson, et al.
Journal of the American Geriatrics Society|March 23, 2006
Risk factors for surgical site infections in older peopleKeith S Kaye, Richard Sloane, Daniel J Sexton, et al.
Pageof 74